liu.seSearch for publications in DiVA
Change search
ReferencesLink to record
Permanent link

Direct link
Hopp om förbättring av överlevnad i ovarialcancer
Avdelningen för cancerepidemiologi, Skånes universitetssjukhus, Lund.
Regionalt cancercentrum Stockholm–Gotland, Stockholm.
Kvinnokliniken, Skånes universitetssjukhus, Lund.
Regionalt cancercentrum Väst, Göteborg.
Show others and affiliations
2015 (Swedish)In: Läkartidningen, ISSN 0023-7205, E-ISSN 1652-7518, Vol. 112, no 50, 2281-3 p.Article in journal (Refereed) Published
Abstract [en]

Ovarian cancer is the most common cause of death from a gynecologic cancer. Every year around 700 women contracts ovarian cancer in Sweden. The overall survival is among the highest in Europe, but still long term relative survival is only 46%. It is a long-held myth that ovarian cancer is a disease without symptoms. Almost 90% of women have symptoms, even in the early stages. Symptoms that should arise suspicion of ovarian cancer and initiate diagnostic work-up are continuous abdominal extension, early feeling of satiety, pelvic or abdominal pain, urinary urge and postmenopausal bleeding. Women's awareness of symptoms and willingness to seek medical advice and the organization of the health care system are important factors determining cancer survival. Ovarian cancer is a heterogeneous group of diseases with different tumor traits and prognosis. Personalized medicine and preventive measures recognizing recent knowledge about tumor biology will positively affect survival.

Abstract [sv]

Ovarialcancer har högst mortalitet bland gynekologiska cancersjukdomar. I Sverige insjuknar årligen ca 700 patienter. Överlevnaden är bland de högsta i Europa, men på en låg nivå, 46 procent.

Nästan 90 procent av kvinnorna har symtom även i tidigt stadium.

Symtom som ska väcka misstanke om ovarialcancer är ihållande utspänd buk, tidig mättnadskänsla, bäcken- eller buksmärta, ökande urinträngningar och postmenopausal blödning.

Kvinnors benägenhet att söka sjukvård och sjukvårdens organisation bidrar till canceröverlevnad.

Ovarialcancer sammanfattar flera sjukdomar med skilda tumörkarakteristika och prognos. Individualiserad behandling och preventiva åtgärder utifrån denna nyvunna kunskap kan komma att inverka positivt på överlevnaden.

Place, publisher, year, edition, pages
2015. Vol. 112, no 50, 2281-3 p.
National Category
Cancer and Oncology
Identifiers
URN: urn:nbn:se:liu:diva-125271PubMedID: 26646961OAI: oai:DiVA.org:liu-125271DiVA: diva2:904366
Available from: 2016-02-18 Created: 2016-02-18 Last updated: 2016-02-29

Open Access in DiVA

No full text

Other links

PubMedläs hela artikeln

Search in DiVA

By author/editor
Åvall Lundqvist, Elisabeth
By organisation
Division of Clinical SciencesFaculty of Medicine and Health SciencesDepartment of Oncology
In the same journal
Läkartidningen
Cancer and Oncology

Search outside of DiVA

GoogleGoogle Scholar
The number of downloads is the sum of all downloads of full texts. It may include eg previous versions that are now no longer available

Altmetric score

Total: 248 hits
ReferencesLink to record
Permanent link

Direct link